Disc Medicine, Inc. (IRON) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$180.39M | -92.1% |
| 2024 | -$93.93M | -27.9% |
| 2023 | -$73.46M | -73.9% |
| 2022 | -$42.25M | -53.5% |
| 2021 | -$27.53M | +15.8% |
| 2020 | -$32.71M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$180.39M | -92.1% |
| 2024 | -$93.93M | -27.9% |
| 2023 | -$73.46M | -73.9% |
| 2022 | -$42.25M | -53.5% |
| 2021 | -$27.53M | +15.8% |
| 2020 | -$32.71M | — |